$HBIO News

Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET

Harvard Bioscience Announces Creation of Scientific Advisory Board

Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript

Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $7.5

Harvard Bioscience, Inc. 2026 Q2 - Results - Earnings Call Presentation

Harvard Bioscience, Inc. Q2 2026 Earnings Call Summary

Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights: Revenue Surges 11% and ...

Harvard Bioscience beats Q2 estimates and raises 2026 revenue guidance

Harvard Bioscience, Inc. (HBIO) Q2 2026 Earnings Call Transcript

Harvard Bioscience Announces Second Quarter 2026 Financial Results

Harvard Bioscience Sees FY2026 Sales $89.147M-$90.877M vs $88.600M Est.

Harvard Bioscience Sees Q3 Sales $21.000M-$22.600M vs $21.850M Est

Harvard Bioscience Q2 Adj. EPS $(0.14) Beats $(0.21) Estimate, Sales $22.727M Beat $21.450M Estimate

Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET

Harvard Bioscience, Inc. 2026 Q1 - Results - Earnings Call Presentation

Harvard Bioscience Inc (HBIO) Q1 2026 Earnings Call Highlights: Revenue Growth Driven by New ...

Harvard Bioscience Inc (NASDAQ:HBIO) Q1 Results Show Revenue Miss Offsets Earnings Beat

Harvard Bioscience Announces First Quarter 2026 Financial Results

Harvard Bioscience, Inc. (HBIO) Q1 2026 Earnings Call Transcript

Harvard Bioscience Q1 2026 Earnings Call Transcript